Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Pradiksi Gunatama Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Pradiksi Gunatama Tbk. diperdagangkan di Rp9.600 (kapitalisasi pasar 55,94 T, volume 24 jam 15,3 rb). Perbedaan utamanya: Pradiksi Gunatama Tbk. jauh lebih besar — sekitar 337× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (324 rb vs 15,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | PGUN | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 55,94 T |
Volume | 324 rb | 15,3 rb |
Lot | 3,24 rb | 153 |
Perputaran | 77,68 jt | 146,97 jt |
Harga Rata-rata | 239,75 | 9.605,56 |
Nilai Transaksi | 77,68 jt | 146,97 jt |
Harga Ekuilibrium Indikatif | 240 | 9.600 |
Volume Ekuilibrium Indikatif | 1 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Pradiksi Gunatama Tbk (Company), was established on September 11, 1995 in the Republic of Indonesia in the framework of foreign investment in accordance with the Domestic Investment Law No. 1 of 1989, Juncto Law No. 12 of 1970, based on deed No. 46 dated June 21, 1996 notary Ny. Toety Juniarto.SH in Jakarta. The Company commenced commercial operations in 2002.
Selengkapnya di halaman PGUN →